Phase I Results of Acalabrutinib in Combination with Durvalumab in Primary Central Nervous System Lymphoma: Safety, Efficacy, and Central Nervous System PenetrationImran A. Nizamuddin,Narendranath Epperla, Mary-Kate Malacek,Brad S. Kahl,Fei Wan,Anne Fischer,Chaz Moreno, Emily R. King, Anna Krivenko,Nancy L. Bartlett,Neha Mehta-ShahBlood(2024)引用 0|浏览2AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要